MoneyWorks4Me

Abbott India reports 39% rise in Q4 net profit

18 May 2022 Evaluate

Abbott India has reported results for fourth quarter and year ended March 31, 2022.

The company has reported a rise of 38.66% in its net profit at Rs 211.41 crore for the quarter under review as compared to Rs 152.47 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 1,276.07 crore for Q4FY22 as compared Rs 1,114.74 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore as compared to Rs 690.69 crore for the previous year. Total income of the company increased by 13.79% at Rs 4,996.48 crore for year under review as compared to Rs 4,390.92 crore for year ended March 31, 2021.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..